Here, we report that hotspot S427F/Y mutations in RXRA or focal amplification/overexpression of PPARG in bladder cancer induce the activation of the PPARγ/RXRα pathway, leading to suppression of cytokine secretion from cancer cells. Here, RXRA is linked to urinary bladder carcinoma.